ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Start-Up Nosis Partners Its AI Pl
Generics BulletinViatris says its US generic glucagon 1mg/vial injectable is “actively being launched,” as the firm looks to deliver on its long-promised string of complex injectables going into a challenging 2025. Ne
Generics BulletinThe US Food and Drug Administration warning letter and import alert currently blocking export of seven of Viatris’ non-shortage-related products from its oral finished dose manufacturing facility in I
ScripBridgeBio Oncology Therapeutics (BBOT), the cancer drug company spun out of rare disease-focused BridgeBio Pharma in May 2024 with $200m in venture capital financing, announced on 28 February that it